Diversified Healthcare Trust

NasdaqGS DHC

Diversified Healthcare Trust Return on Equity (ROE) for the Trailing 12 Months (TTM) ending September 30, 2024

Diversified Healthcare Trust Return on Equity (ROE) is NA for the Trailing 12 Months (TTM) ending September 30, 2024. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.

Diversified Healthcare Trust Return on Equity (ROE) for the Trailing 12 Months (TTM) ending September 30, 2023 was -9.95%, a -167.12% change year over year.
Diversified Healthcare Trust Return on Equity (ROE) for the Trailing 12 Months (TTM) ending September 30, 2022 was 14.82%, a 274.01% change year over year.
Diversified Healthcare Trust Return on Equity (ROE) for the Trailing 12 Months (TTM) ending September 30, 2021 was -8.52%, a -31.44% change year over year.
Diversified Healthcare Trust Return on Equity (ROE) for the Trailing 12 Months (TTM) ending September 30, 2020 was -6.48%, a -25.37% change year over year.

Key data

Date	Return on Equity (ROE)	Return on Capital Employed (ROCE)	Interest Coverage Ratio	Debt to Equity Ratio

NasdaqGS: DHC

Diversified Healthcare Trust

CEO	Mr. Christopher J. Bilotto
IPO Date	Feb. 23, 2000
Location	United States
Headquarters	Two Newton Place
Employees	600
Sector	Real Estate
Industries Health Care REITs Diversified REITs Office REITs Residential REITs

Description

DHC is a real estate investment trust, or REIT, that owns medical office and life science properties, senior living communities and wellness centers throughout the United States. DHC is managed by the operating subsidiary of The RMR Group Inc., an alternative asset management company that is headquartered in Newton, MA.

Key trends

Past 5 years